Los Angeles (Westlake), California

Velocity Clinical Research, Westlake

Velocity's Westlake research site was founded as the National Research Institute, a five-site research network in southern California, and acquired by Velocity in 2021. Our Westlake site offers a wide range of expertise including diabetes, NASH, vaccines, psychiatry, women’s health, and pediatric trials. Westlake’s experienced staff maintains high quality standards and enrollment on all their trials.

Located outside of Los Angeles, the Westlake site is easily accessible for patients through public transport. The Westlake team is bilingual allowing the site to recruit a diverse patient population. The local hospital is located next door to the site. With more than 12,000 square-feet of dedicated research space, they can efficiently and effectively conduct multiple concurrent studies.

All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Westlake team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Velocity Clinical Research, Westlake
2010 Wilshire Blvd, Suite 302, Los Angeles, CA 90057

Phone: (213) 483-1800

Email: info@velocityclinical.com

Find a Clinical Trial in Los Angeles (Westlake)
Sign up below to speak with an enrollment specialist about available research studies in Los Angeles (Westlake).

Follow Velocity on Facebook for company updates and more.

Portrait Of Medical Team Standing Outside Hospital

About Velocity Clinical Research

100,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA).

Our experienced research team in Los Angeles (Westlake)

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Los Angeles (Westlake) is dedicated to conducting quality research in a professional and caring environment.

  • Mark Leibowitz, MD

    Principal Investigator
    Mark Leibowitz, MD is an experienced and skilled Investigator with approximately 25 years of research experience. Dr. Leibowitz has participated in an estimated 500 studies from Phase I-IV across a variety of different indications. As part of his research portfolio, Dr. Leibowitz has conducted highly complex studies in healthy subjects and diverse patient populations including continuous cerebrospinal fluid studies, First in Human, Single and Multiple Ascending Dose studies, Ethnic bridging programs, QTc studies, as well as, serving as Principal Investigator for many adaptive trial designs. His experience includes leadership roles such as Medical Director for research sites located in California and Texas. In addition, he is currently a contributing member for a Data Safety Monitoring Board.

  • Juan Pablo Frias, MD

    Principal Investigator
    Juan Pablo Frías, MD, a native of Chile, completed his undergraduate studies at the University of Florida and received his medical degree from Vanderbilt University School of Medicine. After serving 5 years as a General Medical Officer in the US Navy, he completed his training in Internal Medicine at Vanderbilt University and the University of Tennessee, and his Fellowship in Endocrinology, Diabetes and Metabolism at the University of California, San Diego. Dr. Frías has held leadership positions in Clinical and Medical Affairs at Eli Lilly, Amylin Pharmaceuticals, Pfizer, and Johnson & Johnson, where he served as Chief Medical Officer and Global Vice President of Clinical and Medical Affairs, Diabetes Care. Dr. Frías has held academic positions at the University of Colorado Health Sciences Center, Barbara Davis Center for Diabetes, and the University of California San Diego School of Medicine, where he is currently on the clinical faculty. He is also active in the non-profit organization Taking Control of Your Diabetes (TCOYD), where he lectures at the organization’s Latino Initiative patient conferences and provides continuing medical education for healthcare providers. Dr. Frías has been involved in diabetes and metabolism-related research for over 15 years and has authored numerous publications in this field.

  • Maricor Grio, MD

    Principal Investigator
    Maricor Grio, MD is a clinical research physician with over 15 years of experience. She is a board certified Pediatric Nephrologist and General Pediatrician and graduated from the University of Miami School of Medicine with her medical degree. She is also a NIH Scholar with a Master’s in clinical research design and statistical analysis. Besides Principal Investigator, some of her previous titles include Clinical Assistant Professor of Pediatrics, Pediatric Nephrologist, Medical Director, and Urgent Care Physician. Dr. Grio is passionate about leadership and investigator roles in clinical trials, especially in nephrology, inflammation, pediatrics and medical devices. Her therapeutic experience also includes Endocrinology, Ophthalmology, and Dermatology in adult patients.

  • David_Guzman_MD

    David Guzman, MD

    Principal Investigator
    David Guzman, MD is an experienced board-certified Internist who joined Velocity Clinical Research in 2022. He completed his undergraduate studies at Massachusetts Institute of Technology (MIT) and received his medical degree from the University of Chicago, Pritzker School of Medicine. He completed his postgraduate training in Internal Medicine at Northwestern University McGaw Medical Center and remained there as an Instructor in Clinical Medicine. Dr. Guzman participated in Community Based Clinical Trials at a federally-qualified health center in Chicago from 1990 to 1993. He is a native Spanish speaker and has served various Latino communities in Chicago, south Florida, and now southern California with a focus on providing both primary care and urgent care.

  • John Nelson, PA-C

    Principal Investigator
    John Nelson, PA-C is a skilled Physician Assistant with over 20 years of medical and clinical research experience in a variety of indications such as Pulmonary Medicine and Critical Care, Internal Medicine, Gastroenterology, Infectious Disease, Emergency Medicine, and Geriatrics. He obtained his Physician Assistant certification from the USC School of Medicine. John currently serves as a Sub-Investigator for multiple Velocity sites in the LA area and is a member of the California Academy of Physician Assistants.

Complete the form to start your clinical trial journey in Los Angeles (Westlake)

Beyond helping advance medicine, you may also:

  • Get care from a local doctor at no cost
  • Learn about new medicines in development
  • Receive study-related medical exams at no cost
  • Get paid for participating (amounts differ for each study)

After you submit your info, a Velocity staff member will review your info. They will contact you to talk about the study, or others that may be right for you.

Health insurance is generally not needed to join a clinical trial.

Remember, there is never an obligation to join — we're here to help you make the best decision.

Submit your info

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.